Virtual Pain Care Management (COVID-19)
VCPM
Virtual Pain Care for High Risk Veterans on Opioids During COVID19 (and Beyond)
1 other identifier
interventional
44
1 country
2
Brief Summary
The COVID-19 pandemic is exacerbating the challenges faced by Veterans at risk of opioid overdose including Veterans prescribed moderate-to-high dose long-term opioid therapy (LTOT) whose usual treatment resources and coping strategies may be inaccessible. This project combines established VA care components to deploy and evaluate virtual models of care for Veterans on high-risk LTOT to meet the dual challenges of maintaining social distancing and delivery high quality care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Oct 2020
Shorter than P25 for not_applicable chronic-pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2020
CompletedFirst Posted
Study publicly available on registry
September 7, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 12, 2021
CompletedResults Posted
Study results publicly available
June 14, 2024
CompletedJune 14, 2024
January 1, 2024
8 months
September 3, 2020
June 8, 2022
January 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Number of Patients Who Agree to Change in Their Opioid Regimen, Including Buprenorphine Transfer
Using shared decision-making with Veterans, we will based the measure on clinical reports of patient change in opioid regimen. This would be tapering (reducing opioid dose), discontinuation, or transfer to buprenorphine. Any reduction or change was considered positive for change, even if the patients returned to their initial dose. The number of patients who agree to change their opioid regimen provides a realistic indicator of overall feasibility/acceptability.
30 days
Secondary Outcomes (1)
Number of Participants Retained in Care at End of Study
60 days
Study Arms (1)
VCPM
OTHERVCPM is a multi-component intervention consisting of already-established care processes and materials. First, the patient is mailed or emailed (based on their preference) an informational packet prior to intake appointment. Second, using the collaborative medication management model established in VHA,3 the intake appointment is led by the CPS using a standardized intake evaluation. The CPS and physician design a plan presented to the patient. If BUP switch is offered and accepted, the physician completes additional brief evaluations, including a history, medication review, treatment planning, and discussion of other VCPM components, using two-way audio-video visits (with telephone as a back-up).
Interventions
VCPM is a multi-component intervention consisting of already-established care processes and materials.
Eligibility Criteria
You may qualify if:
- Eligible participants must currently receive LTOT for chronic pain at 50 mg morphine equivalent daily dose
You may not qualify if:
- dementia diagnosis or moderate-severe cognitive impairment
- unstable or severe untreated psychiatric disorder or medical disease that requires hospitalization
- documentation of suspected controlled substance diversion
- inability to communicate by phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, 80045, United States
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, 06516, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Brent Moore
- Organization
- VA Connecticut Healthcare System
Study Officials
- PRINCIPAL INVESTIGATOR
Brent Adams Moore, PhD
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2020
First Posted
September 7, 2020
Study Start
October 1, 2020
Primary Completion
May 31, 2021
Study Completion
August 12, 2021
Last Updated
June 14, 2024
Results First Posted
June 14, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share